IDIOTYPE NETWORKS IN TRANSFUSION-AIDS
输血辅助中的独特型网络
基本信息
- 批准号:3135615
- 负责人:
- 金额:$ 16.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-04-01 至 1989-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS affinity chromatography antiidiotype antibody blood donor blood transfusion communicable disease control communicable disease transmission enzyme linked immunosorbent assay gene expression human T cell lymphotropic virus type 1 human tissue immunoelectron microscopy immunological substance leukocyte activation /transformation serology /serodiagnosis synthetic peptide viral vaccines virus antigen
项目摘要
Transfusion-associated AIDS has become a major health problem as clearly
shown by serologic evidence in the general public and by transmission of
the disease to chimpanzees with plasma from AIDS patients. The
characterization of idiotypic determinants and the generation of
anti-idiotypic reagents have provided powerful tools with which to analyze
and modulate a given immune response. The idiotype network developed
during the course of an immune response provides conceptual insight into
the host response to a given antigen. It is proposed to analyze the
idiotype network initiated by a host in response to a human T-cell
lymphotropic virus type III (HTLV-III) infection or immunization with
HTLV-III. The idiotypes that are expressed on human, chimpanzee and mouse
antibodies to the envelope glycoproteins, gp 120 and gp 41, of HTLV-III
will be examined. The expression of these idiotypic determinants on
antibodies to gp 120 and gp 41 produced in naturally infected and immunized
individuals will be analyzed. The identification of a major common
idiotype(s) in human sera positive for anti-gp 120 and anti-gp 41 will be
used to detect potential variable region antibody gene differences among
AIDS diagnosed individuals and in blood donors containing antibody but
having no disease. The epitopes associated with gp 120 and gp 41 and with
synthetic gp 120 and gp 41 peptides will be identified. In addition, we
will examine the use of anti-idiotypic antibodies for an effective safe
vaccine. The results of these experiments will give insight into whether
idiotype networks, expression of particular idiotypes or both are important
in the host's response to HTLV-III. These anti-idiotype reagents may also
identify serologic markers as indicators of infectivity.
输血相关的艾滋病已成为一个主要的健康问题,
一般公众的血清学证据和
用艾滋病患者的血浆给黑猩猩注射艾滋病病毒。 的
独特型决定因素的表征和
抗独特型试剂提供了强大的工具,
并调节特定的免疫反应。 独特型网络发展了
在免疫反应过程中,
宿主对给定抗原的反应。 建议分析
由宿主响应人T细胞启动的独特型网络
嗜淋巴细胞病毒III型(HTLV-III)感染或免疫
HTLV-III。 在人、黑猩猩和小鼠上表达的独特型
抗HTLV-III包膜糖蛋白gp 120和gp 41的抗体
将被审查。 这些独特型决定因素在细胞上的表达
自然感染和免疫后产生的针对gp 120和gp 41的抗体
将对个人进行分析。 确定一个主要共同点
抗gp120和抗gp41阳性人血清中的独特型将被
用于检测潜在的可变区抗体基因差异,
艾滋病确诊者和献血者中含有抗体,
没有疾病。 与gp120和gp41相关的表位以及与
将鉴定合成的GP 120和GP 41肽。 另外我们
将检查抗独特型抗体的使用,
疫苗 这些实验的结果将使我们深入了解,
独特型网络、特定独特型的表达或两者都很重要
对HTLV-III病毒的反应 这些抗独特型试剂还可以
确定血清学标志物作为传染性指标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GORDON R DREESMAN其他文献
GORDON R DREESMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GORDON R DREESMAN', 18)}}的其他基金
JEOL MODEL JEM-1200EX/DP/DP TEMSCAN ANALYTICAL ELECTRON
JEOL 型号 JEM-1200EX/DP/DP TEMSCAN 分析电子
- 批准号:
3520491 - 财政年份:1989
- 资助金额:
$ 16.42万 - 项目类别:
ASSAY METHODS TO DETECT ANTIGENIC MARKERS FOR AIDS
检测艾滋病抗原标记的测定方法
- 批准号:
3343855 - 财政年份:1984
- 资助金额:
$ 16.42万 - 项目类别:
ASSAY METHODS TO DETECT ANTIGENIC MARKERS FOR AIDS
检测艾滋病抗原标记的测定方法
- 批准号:
3343854 - 财政年份:1984
- 资助金额:
$ 16.42万 - 项目类别:
MAINTENANCE OF CHIMPANZEES FOR HEPATITIS RESEARCH
维持黑猩猩用于肝炎研究
- 批准号:
3645050 - 财政年份:1982
- 资助金额:
$ 16.42万 - 项目类别:
MAINTENANCE OF CHIMPANZEES FOR HEPATITIS RESEARCH
维持黑猩猩用于肝炎研究
- 批准号:
3645049 - 财政年份:1982
- 资助金额:
$ 16.42万 - 项目类别:
MAINTENANCE OF CHIMPANZEES FOR HEPATITIS RESEARCH
维持黑猩猩用于肝炎研究
- 批准号:
3645048 - 财政年份:1982
- 资助金额:
$ 16.42万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 16.42万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 16.42万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 16.42万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 16.42万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 16.42万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 16.42万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 16.42万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 16.42万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 16.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 16.42万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




